[3,3]-Sigmatropic Rearrangements of Naphthyl 1-Propargyl Ethers: para-Propargylation and Catalytic Asymmetric Dearomatization

The para-Claisen rearrangement of aryl 1-propargyl ethers involves two-step [3,3]-sigmatropic rearrangements and dearomatization process, which has high activation barriers and is of challenge. Here we discovered thermal para-Claisen rearrangement of naphthyl 1-propargyl ethers, and it enabled the formation of formal para-C-H propargylation products upon rearomatization. Chirality transfer occurred if optically active propargyl ethers were employed, leading to the construction of aryl/propargyl-containing stereogenic centers. Moreover, catalytic asymmetric dearomatization of naphthyl 1-propargyl ethers with different substitution at para-position gave access to benzocyclohexenones bearing all-carbon quaternary stereocenters. The reaction was accelerated by a chiral N,N'-dioxide/Co(OTf)₂ complex catalyst to achieve high yields (up to 98 %) and high enantioselectivities (up to 93 % ee). The DFT calculations and experimental results provided important clues to clarify the para-Claisen rearrangement process as well as the chiral induction and remote delivery.

ASYMMETRIC SYNTHESIS: A GLANCE AT VARIOUS METHODOLOGIES FOR DIFFERENT FRAMEWORKS

Abstract:

Asymmetric reactions have made a significant advancement over the past few decades and involved the production of enantiomerically pure molecules using enantioselective organocatalysis, chiral auxiliaries/substrates, and reagents via controlling the absolute stereochemistry. The laboratory synthesis from an enantiomerically impure starting material gives a combination of enantiomers which are difficult to separate for chemists in the fields of medicine, chromatography, pharmacology, asymmetric synthesis, studies of structure-function relationships of proteins, life sciences and mechanistic studies. This challenging step of separation can be avoided by the use of asymmetric synthesis. Using pharmacologically relevant scaffolds/pharmacophores, the drug designing can also be achieved using asymmetric synthesis to synthesize receptor specific pharmacologically active chiral molecules. This approach can be used to synthesize asymmetric molecules from wide variety of reactants using specific asymmetric conditions which is also beneficial for environment due to less usage and discharge of chemicals into the environment. So, in this review, we have focused on the inclusive collation of diverse mechanisms in this area, to encourage auxiliary studies of asymmetric reactions to develop selective, efficient, environment-friendly and high yielding advanced processes in asymmetric reactions.

Efficient Synthesis of Chiral Trisubstituted 1,2-Allenyl Ketones by Catalytic Asymmetric Conjugate Addition of Malonic Esters to Enynes

An N,N'-dioxide/scandium(III) complex catalyzed, highly efficient conjugate addition of malonic esters to enynes is described. A range of trisubstituted 1,2-allenyl ketones were obtained in high yields (up to 99 %) with good d.r. (up to 95/5) and excellent ee values (97 %-99 %). Moreover, the products could be easily transformed into chiral furan and 5-hydroxypyrazoline derivatives, both of which are important skeletons of many biologically active compounds and pharmacologicals.